The present invention relates to the delivery of
caffeine through an
inhalation route. Specifically, it relates to aerosols containing
caffeine that are used in
inhalation therapy. In a composition aspect of the present invention, the
aerosol comprises particles comprising at least 5 percent by weight of
caffeine. In a method aspect of the present invention, caffeine is delivered to a
mammal through an
inhalation route. The method comprises: a) heating a composition, wherein the composition comprises at least 5 percent by weight of caffeine, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation
aerosol comprising particles, which is inhaled by the
mammal. In a kit aspect of the present invention, a kit for delivering caffeine through an inhalation
route to a
mammal is provided which comprises: a) a composition comprising at least 5 percent by weight of caffeine; and, b) a device that forms a caffeine containing
aerosol from the composition, for inhalation by the mammal.